ESMO Breast Cancer 2023 Congress Coverage

 

ESMO Breast Cancer 2023 Congress Coverage
T

ESMO Breast Cancer 2023 DORA Phase 2 Study: Durvalumab and Olaparib in Platinum-Treated Advanced TNBC

By ESMO Breast Cancer 2023 Congress Coverage FEATURING Tira Tan
By ESMO Breast Cancer 2023 Congress Coverage FEATURING Tira Tan
42 views
May 24, 2023
0 Comments
Login to view comments. Click here to Login
Videos
19:34
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Clinical Impact of Evolving ADC Technology

Feat. H. McArthur
10:48
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Results of Part B of SOLTI TOT-HER3 Window o…

Feat. M. Oliveira
16:20
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023: Role of Germline Genetic Testing in Early B…

Feat. S. Lee
07:49
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…

Feat. H. Rugo
17:44
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Phase 3 DESTINY-Breast04 Trial Safety Analys…

Feat. H. Rugo
14:38
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Phase 3b LUCY Trial Subgroup Analysis: Clini…

Feat. K. Gelmon
17:03
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Clinical Implementation of Oral SERD: Presen…

Feat. C. Criscitiello
10:06
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 DORA Phase 2 Study: Durvalumab and Olaparib …

Feat. T. Tan
14:11
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Highlights: Key Studies Including IMPassion0…

Feat. P. Tarantino
16:58
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023: Who Really Benefits From IO? Can We Identif…

Feat. J. Balko
09:56
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 EMERALD Trial: Analysis of PROs in Patients …

Feat. J. Cortes
05:47
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 DATA Trial Analysis: The Prognostic and Pred…

Feat. S. Lammers